Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Johnson & Johnson (NY: JNJ )

146.82 -1.71 (-1.15%)
Official Closing Price Updated: 4:10 PM EDT, Apr 25, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 7,594,315
Open 149.37
Bid (Size) 146.76 (2)
Ask (Size) 146.99 (3)
Prev. Close 148.53
Today's Range 146.33 - 149.58
52wk Range 143.13 - 175.97
Shares Outstanding 2,628,679,824
Dividend Yield 3.24%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
The Top 3 Small-Cap Stocks to Buy in April 2024
These top small-cap stocks offer investors diversification across multiple segments but boast a strong standing on their own merits. 
Via InvestorPlace
US Stock: Johnson & Johnson
Johnson & Johnson, through its subsidiaries, is engaged in the research and development, manufacture, and sale of a range of products in the healthcare field. 
Via Talk Markets

Performance

YTD
-8.22%
-8.22%
1 Month
-5.41%
-5.41%
3 Month
-7.64%
-7.64%
6 Month
-3.13%
-3.13%
1 Year
-11.12%
-11.12%

More News

Read More
Balancing Dividends and Fundamentals: The Case of NYSE:JNJ.
Via Chartmill
7 blue chip stocks to Buy on the Dip: April 2024
Via InvestorPlace
Medtech Marvels: 3 Groundbreaking Medical Device Stocks to Watch in 2024
Via InvestorPlace
Johnson & Johnson Stocks Elliott Wave Technical Analysis
Via Talk Markets
The Top 7 Dividend Stocks to Buy in 2024 to Build Lasting Wealth
Via InvestorPlace
These Are the 10 High-Profile Stocks U.S. Politicians Have Gravitated to Most Over the Last 3 Years
Via The Motley Fool
Got $5,000? Here Are 3 Undervalued Stocks to Buy and Hold Forever
Via The Motley Fool
Warning! These 3 Blue-Chip Stocks Will Have You Seeing Red
Via InvestorPlace
No. 1 Biotech Stock Neurocrine Launches Higher On Depression Treatment Win
Via Investor's Business Daily
Johnson & Johnson to Participate in the Bernstein’s 40th Annual Strategic Decisions Conference (SDC)
From Johnson & Johnson
Via Business Wire
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Macatawa Bank Corporation (Nasdaq - MCBC), Shockwave Medical, Inc. (Nasdaq – SWAV), Apartment Income REIT Corp. (NYSE - AIRC), Model N, Inc. (NYSE – MODN)
From Brodsky & Smith LLC
Via GlobeNewswire
3 Dividend Stocks to Buy Now for Lifelong Income
Via InvestorPlace
5 Crash-Proof Stocks to Buy Immediately
Via InvestorPlace
3 Dividend Kings Down 11% You’ll Regret Not Buying on the Dip
Via InvestorPlace
MarketBeat Week in Review – 4/15 - 4/19
Via MarketBeat
Topics Economy
Exposures Interest Rates
Investing for the Long-Term: 3 Stocks With Proven Track Records
Via InvestorPlace
Topics Economy
Exposures Economy
These 3 Small-Cap Stocks Are Up 304% in 2024. Can They Run Higher?
Via InvestorPlace
Stock Market Sells Off; Taiwan Semi, ASML, Netflix, Tesla In Focus: Weekly Review
Via Investor's Business Daily
Topics Stocks
Exposures US Equities
Brexit Impact On Drugs - Rising Shortages in UK Highlight Brexit Challenges
Via Benzinga
Topics Brexit
Exposures Brexit
Johnson & Johnson Children's Cough Syrup Contaminated In Some Batches - WHO Poised to Issue Global Alert
Via Benzinga
Topics Product Recall
Exposures Legal Product Safety
FDA Mandates "Boxed Warning" For Bristol Myers, Johnson & Johnson CAR-T-Based Blood Cancer Therapies
Via Benzinga
Exposures Product Safety
Top Stock Reports For Nvidia, Alphabet And Johnson & Johnson
Via Talk Markets
Recession-Proof Riches: 3 Stocks That Thrive in Any Economy
Via InvestorPlace
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.